scorecardresearch
Biocon

Biocon

 

More Stories on Biocon
Stocks in news today: Indiabulls Housing, Axis Bank, United Breweries, NTPC, United Breweries, Biocon and more

Stocks in news: Zee Entertainment, Indiabulls Housing, Axis Bank, United Breweries, NTPC and more

Sep 27, 2021

Stocks in news today: Indiabulls Housing, Axis Bank, United Breweries, NTPC, United Breweries, Biocon and more

USFDA conducted an on-site pre-approval inspection of the company's Malaysian subsidiary Biocon Sdn Bhd's manufacturing facility (Representational Image)

USFDA issues six observations post inspection of Biocon's Malaysian arm manufacturing facility

Sep 25, 2021

A Biocon spokesperson said the company is confident of addressing the observations through procedural enhancements and an appropriate Corrective and Preventive Action Plan (CAPA)

Biocon will have access to 100 million doses of Serum's vaccines annually for 15 years

Biocon-Serum alliance to build a global biotech powerhouse, say Kiran Mazumdar-Shaw, Adar Poonawalla

Sep 17, 2021

Speaking at a press conference today, they said the synergistic future oriented deal will help growth of both companies

Stocks in news: Poonawalla Fincorp, Biocon, JSW Steel, Kotak Mahindra Bank and more

Stocks in news: Poonawalla Fincorp, Biocon, JSW Steel, Kotak Mahindra Bank and more

Sep 17, 2021

On September 16, Sensex closed above the 59,000 mark for the first time, led by gains in banking stocks. Nifty too ended above 17,600 level, with 28 of 50 components ending in the green.

Biocon Biologics, Serum Institute Life Sciences enter strategic alliance

Biocon Biologics offers 15% stake to Serum Institute Life Sciences

Sep 17, 2021

The alliance will also develop antibodies in order to target diseases such as dengue, HIV etc. Both companies will enter Service Level Agreements (SLAs) for manufacturing and distribution of these vaccines and antibodies

Biosimilars segment posted a revenue of Rs 758 crore for the first quarter ended June 30, 2021 (Source: PTI)

Biocon net profit falls 35% to Rs 108 crore in Apr-Jun

Jul 23, 2021

Consolidated revenue of the company stood at Rs 1,807.8 crore for the quarter under consideration. It was at Rs 1,712.1 crore for the same period a year ago.

Sebi bars Biocon official from securities market

Sebi bars Biocon official from securities market, slaps penalty worth Rs 2 lakh

Jul 01, 2021

Senior vice president of Biocon, Shreehas P Tambe, being an insider traded in the shares of the firm between December 19-27, 2017, in violation of market norms

Syngene targets supplying 500,000 Remdesivir vials in India amid COVID-19 surge

May 27, 2021

Syngene, majority owned by biopharmaceutical company Biocon Ltd, is one of the seven Indian companies that have licensed remdesivir from U.S.-based Gilead Sciences Inc

SEBI fines Biocon for violating market norms

May 19, 2021

Designated person of the firm, Narendra Chirmule, who was employed with the company as senior vice president-R&D is facing a fine of Rs 5 lakh for trading in the company's securities when the trading window was closed

States must have the freedom to plan the vaccination: Kiran Shaw

May 12, 2021

Kiran Mazumdar-Shaw, Executive Chairman, Biocon said the Indian government placed orders for vaccines very late in April which was now causing a shortage and chaos. In a conversation with India Today, Shaw said that the government should have initiated the order request for the required vaccines at the start of the year itself. The Biocon Chief added that the problem lay with the Logistics and planning processes, a weakness of the Indian government. Watch as she explains how decentralisation was necessary and how states must have the freedom for dealing with the vaccination process.

Also Read: Kiran Mazumdar Shaw expresses concern over COVID-19 vaccine shortage

Biocon Chief Kiran Mazumdar Shaw questions India's COVID vaccine policy

May 12, 2021

Biocon Executive Chairman Kiran Mazumdar-Shaw has expressed concern over the shortage of COVID-19 vaccines and sought better transparency from the government regarding their availability so that citizens could patiently wait for their turn. "Can we please know where the 70 million doses are being deployed every month? We need better transparency to avoid suspense. If a timetable of supplies is made public people can patiently wait their turn", said Shaw in a tweet on Tuesday while tagging the Health Ministry. Earlier this month, the Health Ministry had noted that a 100 per cent advance of Rs 1,732.50 crore was released to the Serum Institute of India (SII) on April 28 for 11 crore doses of Covishield vaccine. The ministry had also stated that against the last order of 10 crore doses for supplies of Covishield vaccine, 8.744 crore doses had been delivered till May 3. Watch the video for more.

Also Read: Kiran Mazumdar Shaw expresses concern over COVID-19 vaccine shortage